Increased T cell immunoglobulin and mucin domain 3 Positively Correlate with Systemic IL-17 and TNF-A level in the acute phase of ischemic stroke

Journal of Clinical Immunology

Volumn 31, Issue 4, 2011, Pages 719-727

  Zhao, Di ^a   Hou, Nan ^a   Cui, Min ^a   Liu, Ying ^a   Liang, Xiaohong ^a   Zhuang, Xuewei ^b   Zhang, Yuanyuan ^a   Zhang, Lining ^a   Yin, Deling ^c   Gao, Lifen ^a   Zhang, Yun ^a   Ma, Chunhong ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c East Tennessee State University   (United States)

Author keywords

IL 17; Ischemic stroke; Tim 3; TNF alpha

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 17; MEMBRANE PROTEIN; T LYMPHOCYTE IMMUNOGLOBULIN AND MUCIN DOMAIN PROTEIN 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID BLOOD LEVEL; MALE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; REGULATORY MECHANISM; REPERFUSION INJURY;

ACUTE DISEASE; AGED; ANIMALS; ANTIGENS, CD14; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-17; ISCHEMIA; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MIDDLE AGED; REPERFUSION INJURY; STROKE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80555155594     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9534-6     Document Type: Article

References (32)

1. Hankey GJ. Stroke: How large a public health problem and how can the neurologist help? Arch Neurol. 1999;56(6):748-54. (Pubitemid 29266478)
2. Mitchell SV, Elkind, Tai W, Kristen C, Paik MC, Sacco RL. Highsensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Arch Intern Med. 2006; 166: 2073-80. (Pubitemid 44631394)
3. Nobuya I, Olga P, Reuhl KR, Oleg M. Inflammatory response and glutathione peroxidase in a model of stroke. J Immunol.2002;168:1926-33. (Pubitemid 34135795)
4. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: Design, methods, and baseline characteristics. Stroke.1988;19:547-54.
5. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006;26:654-65.
6. Vogelgesang A, Grunwald U, Langner S, Jack R, Bröker BM, Kessler C, et al. Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke. 2008;39:237-41.
7. Ross AM, Hurn P, Perrin N, Wood L, Carlini W, Potempa K. Evidence of the peripheral inflammatory response in patients with transient ischemic attack. J Stroke Cerebrovasc Dis. 2007;16:203-7. (Pubitemid 47369191)
8. Yang QW, Li JC, Lu FL, Wen AQ, Xiang J, Zhang LL, et al. Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J Cereb Blood Flow Metab. 2008;28:1588-96.
9. Monney L, Sabatos CA, Gaglia JL, Ryu A, Waldner H, Chernova T, et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 2002;415:536-41. (Pubitemid 34130609)
10. Kuchroo VK, Umetsu DT, DeKruyff RH, Freeman GJ. The TIM gene family: Emerging roles in immunity and disease. Nat Rev Immunol. 2003;3:454-62. (Pubitemid 37339185)
11. Khademi M, Illés Z, Gielen AW, Marta M, Takazawa N, Baecher- Allan C, et al. T cell Ig- and mucindomain- containing molecule-3 (TIM-3) and TIM-1 molecules are differentially expressed on human Th1 and Th2 cells and in cerebrospinal fluid-derived mononuclear cells in multiple sclerosis. J Immunol. 2004;172:7169-76. (Pubitemid 38669161)
12. Anderson AC, Anderson ED, Bregoli L, Hastings WD, Kassam N, Charles L, et al. Promotion of tissue inflammation by the immune receptor TIM-3 expressed on innate immune cells. Science. 2007;318:1141-3. (Pubitemid 350134897)
13. Sánchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, et al. Tim-3 inhibits T helper type 1-mediated autoand alloimmune responses and promotes immunological tolerance. Nat Immunol. 2003;4:1093-101. (Pubitemid 37428037)
14. Zhao J, Zhang L, Liu Y, Li B, Zhang L, Fang H, et al. Human pregnancy up-regulates Tim-3 in innate immune cells for systemic immunity. J Immunol. 2009;182:6618-24.
15. Yang G, Kitagawa K, Matsushita K, Mabuchi T, Yagita Y, Yanagihara T, et al. C57BL/6 strain is most susceptible to cerebral ischemia following bilateral common carotid occlusion among seven mouse strains: Selective neuronal death in the murine transient forebrain ischemia. Brain Res. 1997;752:209-18. (Pubitemid 27143916)
16. Fujii M, Hara H, Meng W, Vonsattel J, Huang Z, Moskowitz MA. Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. Stroke. 1997;28:1805-11. (Pubitemid 27391453)
17. Wang Y, Meng J, Wang X, Liu S, Shu Q, Gao L, et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol. 2008;67:63-70. (Pubitemid 350209587)
18. Vogelgesang A, May VE, Grunwald U, Bakkeboe M, Langner S, Wallaschofski H, et al. Functional status of peripheral blood Tcells in ischemic stroke patients. PLoS ONE. 2010;5:e8718.
19. Vila N, Castillo J, Dávalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000;31:2325-9.
20. Vila N, Castillo J, Dávalos A, Esteve A, Planas AM, Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003;34:671-5. (Pubitemid 36307391)
21. Castellanos M, Castillo J, García MM, Leira R, Serena J, Chamorro A, et al. Inflammation-mediated damage in progressing lacunar infarctions: A potential therapeutic target. Stroke.2002;33:982-7. (Pubitemid 34293579)
22. Chamorro A, Planas AM. Inflammation-mediated damage as a potential therapeutic target in acute ischemic stroke. Ernst Schering Res Found Worksho. 2004;47:185-204.
23. Frisancho-Kiss S, Nyland JF, Davis SE, Masheka V, Barrett, Gatewood SJL, et al. T cell Ig mucin-3 reduces inflammatory heart disease by increasing CTLA-4 during innate immunity. J Immunol. 2006;176:6411-5. (Pubitemid 43787822)
24. Tziomalos K, Athyros VG, Karaqiannis A, Mikhailidis DP. Dyslipidemia as a risk factor for ischemic stroke. Curr Top Med Chem. 2009;9:1291-7.
25. Sierra-Johnson J, Somers VH, Kuniyoshi FH, Garza CA, Isley WL, Gami AS, et al. Comparison of apolipoprotein-B/apolipoprotein- A1 in subjects with versus without the metabolic syndrome. Am J Cardiol. 2006;98:1369-73. (Pubitemid 44666643)
26. Hallenbeck JM. The many faces of tumor necrosis factor in stroke. Nat Med. 2002;8:1363-8. (Pubitemid 36019420)
27. Sotgiu S, Zanda B, Marchetti B, Fois ML, Arru G, Pes GM, et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol. 2006;13:505-13. (Pubitemid 43823367)
28. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 1997;28:1233-44. (Pubitemid 27248902)
29. Kostulas N, Pelidou SH, Kivisäkk P, Kostulas PV, Link H. Increased IL-1β, IL-8, and IL-17 mRNA expression in blood mononuclear cells observed in a prospective ischemic stroke study. Stroke. 1999;30:2174-9. (Pubitemid 29473266)
30. Shichita T, Sugiyama Y, Ooboshi H, Sugimori H, Nakagawa R, Takada I, et al. Pivotal role of cerebral interleukin-17-producing gammadelta T cells in the delayed phase of ischemic brain injury. Nat Med. 2009;15:946-50.
31. Nakae S, Iwakura Y, Suto H, Galli SJ. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 2007;81:1258-68. (Pubitemid 46702045)
32. Li G-Z, Zhong D, Yang L-M, Sun B, Zhong Z-H, Yin Y-H, et al. Expression of interleukin-17 in ischemic brain tissue. Scand J Immuno. 2005;62:481-6. (Pubitemid 41719324)